Shen SJ - Search Results

1

Effect of yangxinkang tablets on chronic heart failure: A multi-center randomized double-blind placebo-controlled trial.

Xian SX, Yang ZQ, Ren PH, Ye XH, Ye SL, Wang QH, Wang ZH, Shen SJ, Huang XW. Xian SX, et al. Among authors: shen sj. Chin J Integr Med. 2015 Oct;21(10):733-42. doi: 10.1007/s11655-015-2170-x. Epub 2015 May 6. Chin J Integr Med. 2015. PMID: 25948124 Clinical Trial.

2

[Characteristics of Epidermal Growth Factor Receptor with Rare Mutations in Non-small Cell Lung Cancer and the Effect of EGFR Tyrosine Kinase Inhibitors on Them].

Shi Y, Li P, Li B, Zhang F, Huang S, Shen S, Li X. Shi Y, et al. Zhongguo Fei Ai Za Zhi. 2019 May 20;22(5):299-305. doi: 10.3779/j.issn.1009-3419.2019.05.06. Zhongguo Fei Ai Za Zhi. 2019. PMID: 31109439 Free PMC article. Chinese.

3

Corrigendum: Advanced HCC with amplified mesenchymal epithelial transition factor receptor responds well to savolitinib: a case report.

Yan N, Zhang Z, Guo S, Shen S, Li X. Yan N, et al. Front Med (Lausanne). 2023 Jul 26;10:1256685. doi: 10.3389/fmed.2023.1256685. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37564044 Free PMC article.

4

[Association between the ALK Gene Status and the Efficacy of First-line  Pemetrexed Chemotherapy in Patients with Advanced Lung Adenocarcinoma].

Chen M, Cao H, Ji Y, Mao Y, Shen S, Li X. Chen M, et al. Zhongguo Fei Ai Za Zhi. 2017 Nov 20;20(11):732-736. doi: 10.3779/j.issn.1009-3419.2017.11.02. Zhongguo Fei Ai Za Zhi. 2017. PMID: 29167001 Free PMC article. Chinese.

5

[Association between the HER2 Gene Status and the Efficacy of First-line Pemetrexed Combined with Platinum Chemotherapy in Patients with Advanced Lung  Adenocarcinoma].

Li P, Li B, Shi Y, Zhang F, Shen S, Li X. Li P, et al. Zhongguo Fei Ai Za Zhi. 2019 Mar 20;22(3):137-142. doi: 10.3779/j.issn.1009-3419.2019.03.03. Zhongguo Fei Ai Za Zhi. 2019. PMID: 30909992 Free PMC article. Chinese.

6

Alectinib versus crizotinib in ALK-positive advanced non-small cell lung cancer and comparison of next-generation TKIs after crizotinib failure: Real-world evidence.

Wang Y, Shen S, Hu P, Geng D, Zheng R, Li X. Wang Y, et al. Cancer Med. 2022 Dec;11(23):4491-4500. doi: 10.1002/cam4.4834. Epub 2022 May 26. Cancer Med. 2022. PMID: 35616090 Free PMC article.

7

Prognosis of the intrahepatic cholangiocarcinoma after resection: hepatitis B virus infection and adjuvant chemotherapy are favorable prognosis factors.

Liu RQ, Shen SJ, Hu XF, Liu J, Chen LJ, Li XY. Liu RQ, et al. Among authors: shen sj. Cancer Cell Int. 2013 Oct 18;13(1):99. doi: 10.1186/1475-2867-13-99. Cancer Cell Int. 2013. PMID: 24139471 Free PMC article.

8

[The distribution of donor hematopoietic stem cell and the ratio of lymphocytes from donor origin to recipient origin in recipient mice after allogeneic bone marrow transplantation].

Shen SJ, Li XY, Wang LP. Shen SJ, et al. Zhonghua Xue Ye Xue Za Zhi. 2005 Jul;26(7):393-6. Zhonghua Xue Ye Xue Za Zhi. 2005. PMID: 16251017 Chinese.

9

BRAF-Mutated Non-Small Cell Lung Cancer: Current Treatment Status and Future Perspective.

Yan N, Guo S, Zhang H, Zhang Z, Shen S, Li X. Yan N, et al. Front Oncol. 2022 Mar 31;12:863043. doi: 10.3389/fonc.2022.863043. eCollection 2022. Front Oncol. 2022. PMID: 35433454 Free PMC article. Review.

10

Camrelizumab combined with anlotinib as second-line therapy for metastatic or recurrent small cell lung cancer: a retrospective cohort study.

Shen S, Li X, Guo S, Xu L, Yan N. Shen S, et al. Front Oncol. 2024 Jul 8;14:1391828. doi: 10.3389/fonc.2024.1391828. eCollection 2024. Front Oncol. 2024. PMID: 39040456 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters